Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.
Bond yields were steady Friday as investors awaited the latest update on inflation and the economy.
Research showing how the brain reacts to putting can be applied to investing says DataTrek
“She has a next-door neighbor who is 72 and disabled, and has even more serious problems.”
Victor Shvets, the global head of desk strategy for Macquarie Capital and author of a book that compares the current global fractures to the 1930s, says right now is a period of “twilights” without recessions or sharp recoveries.
After languishing 12 years on the market, the former NBA star’s largely abandoned property is getting attention again.
Apple and Nvidia are reportedly in talks to participate in a multi-billion dollar fundraising round led by Thrive Capital that would see them invest in OpenAI alongside Microsoft
Democratic presidential nominee Kamala Harris on Thursday offered a response to the criticism that she already should have implemented some of her economic proposals, with her remarks coming in a much-anticipated interview with CNN’s Dana Bash.
Dell Technologies Inc. should be back in Wall Street’s good graces after Thursday’s fiscal second-quarter results showed that it can post solid profits in AI servers — a big turnaround from the previous quarter.
Earnings season ends, Fed easing begins, and why it makes sense to look outside of the U.S. market.
In this week’s ETF Wrap, we look at small-cap stocks and funds, which many investors think are due for a rebound after Federal Reserve Chair Jerome Powell finally set the table for interest-rate cuts ahead.
Republican presidential nominee Donald Trump on Thursday rolled out a new proposal aimed at people relying on in vitro fertilization. Democrats have criticized Trump over the challenges faced by IVF doctors and patients in the wake of the Supreme Court’s 2022 Dobbs decision.
Prices for the famous tennis cocktail have been raised six times since 2012.
Shares of Lululemon Athletica fell after hours on Thursday after the yoga-wear maker and retailer cut its full-year outlook, further fueling Wall Street’s worries that the years-long trend toward athleisure has run its course.
Shares of Ulta Beauty Inc. dropped more than 8% in the extended session Thursday after the specialty retailer reported worse-than-expected quarterly earnings, cut its guidance, and showed a drop in same-store sales against expectations of an increase.
The semiconductor company is benefiting from AI traction and expects growing operating leverage.
Demand for Dell’s AI servers was up 23% sequentially in the latest quarter.
“Outside of COVID, this is the worst and most competitive job market I’ve seen in 20 years,” one recruiter said.
A new report on the 100 S&P 500 companies with the lowest median pay finds the buyback machine is still in overdrive.
Interest due on the national debt costs more than $3 billion each day, including the weekends.